EUVIMEDEUVIMED entdecken
Crossref

Porous GelMA microneedle with delivery of AIE molecules via HSF-derived exosomes for hypertrophic scar treatment

Zeming Liu, Lingbo Zhang, Bo Yuan, Shuyi Wei, Meng Lyu

Biomedical Microdevices · 2026

DOI: 10.1007/s10544-026-00820-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedical Microdevices, 2026. Verfasst von Zeming Liu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Plastic and Cosmetic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, Ch…. Hauptthemen laut MEDLINE: Cicatrix, Hypertrophic, Fibroblasts, Exosomes, Gelatin. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: the National Natural Science Foundation of China, the Hubei Province Key Research and Development Project, he Peking University People's Hospital Scientific Research Development Funds.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hypertrophic scarring (HS) occurs after surgery or wounding, leading to tissue dysfunction and damaging the appearance. However, no satisfactory treatment strategy is available because the demand for eliminating hypertrophic scar fibroblasts (HSFs) in HS remains unfulfilled. Here, aggregation-induced emission molecule (TTMN)-based porous gelatin methacryloyl microneedles (MNs) were fabricated. The TTMNs were encapsulated in HSF-derived exosomes, which were subsequently assembled in the MN patch. This MN patch exhibited good biocompatibility. When the porous MN patch was applied to the HS, it released exosome-encapsulated TTMN (TE) in the deep skin tissue, triggering a burst of abundant reactive oxygen species in the HS under light irradiation. This event led to marked inhibition of the proliferation and migration of HSFs and collagen deposition in these cells. The application of TE-loaded porous MN patches significantly prevented HS formation in the New Zealand rabbit model of HS, as evidenced by a remarkable decrease in the scar elevation index and collagen I deposition. Thus, this study offers a feasible, convenient, and effective strategy for applying aggregation-induced emission-encapsulated HSF-derived exosome-based porous MNs for the treatment of fibrotic skin diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cicatrix, HypertrophicFibroblastsExosomesGelatinNeedlesAnimalsRabbitsMicroneedle Drug DeliveryPorosityHumansMethacrylates

Stichwörter der Autor:innen

AIEExosomesHypertrophic scarringMicroneedle patchesPhotodynamic therapy

Substanzen

Gelatingelatin methacryloylMethacrylates

Autor:innen und Institutionen

  • Department of Plastic and Cosmetic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
  • Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
  • Department of Science and Education, The Fourth People's Hospital of Shenzhen, Shenzhen, 518118, China. 13825258808@163.com.
  • Peking University People's Hospital, No. 11 Xizhimen South Street, Xicheng District, Beijing, China. 0062046250@pku.edu.cn.
  • Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China. lyumeng@tjh.tjmu.edu.cn.
  • Department of Science and Education, The Fourth People's Hospital of Shenzhen, Shenzhen, 518118, China. lyumeng@tjh.tjmu.edu.cn.

Förderung

  • the National Natural Science Foundation of China
  • the Hubei Province Key Research and Development Project
  • he Peking University People's Hospital Scientific Research Development Funds

Zitieren

APA

Liu, Z., Zhang, L., Yuan, B., Wei, S., & Lyu, M. (2026). Porous GelMA microneedle with delivery of AIE molecules via HSF-derived exosomes for hypertrophic scar treatment. Biomedical Microdevices. https://doi.org/10.1007/s10544-026-00820-2

Vancouver

Liu Z, Zhang L, Yuan B, Wei S, Lyu M. Porous GelMA microneedle with delivery of AIE molecules via HSF-derived exosomes for hypertrophic scar treatment. Biomedical Microdevices. 2026. doi:10.1007/s10544-026-00820-2

BibTeX
@article{Liu2026,
  author = {Liu, Zeming and Zhang, Lingbo and Yuan, Bo and Wei, Shuyi and Lyu, Meng},
  title = {Porous GelMA microneedle with delivery of AIE molecules via HSF-derived exosomes for hypertrophic scar treatment},
  journal = {Biomedical Microdevices},
  year = {2026},
  doi = {10.1007/s10544-026-00820-2}
}
Kostenlos starten →